Purchase Order 75N92025P00337
Award Date
8/25/25
Potential Completion Date
11/25/25
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,978.80 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, part of the Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic products. The contract requires Qiagen to provide QIAsymphony DSP circulating DNA kits to isolate cell-free DNA from plasma samples from lung transplant patients. This is likely in support of the agency's biomedical research and public health programs. The...
This is a $13,573.60 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The contract is for maintenance services on Qiagen's QIASYMPHONY SP 34311 equipment used to isolate cell-free DNA from lung transplant patient plasma samples. The contract period of performance is from August 1, 2025 to July 31, 2026. There is no...
This is a firm fixed-price BPA call awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian federal agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The $21,471.60 contract is for the supply of Qiagen's library preparation reagents to support DNA sequencing and RNA sequencing work at the agency's DNA Sequencing Core. The contract does not utilize any set-aside designations. Qiagen is a critical supplier of...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
This contract award is for the purchase of QIAGEN KITS from Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $14,673.60 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). This purchase order contract does not have a set-aside designation. Qiagen provides a range of sample and assay technologies, including DNA/RNA extraction kits,...
This is a $12,060 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for maintenance services on Qiagen's EZ2 Connect and QIAcuity One instruments used for isolation and analysis of cell-free DNA. The contract has an ultimate completion date of August 15, 2026. Qiagen has established itself as a critical...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
This is a $13,789.48 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is for the provision of QuantiFast probe kits, RNeasy kits, tubes, and caps, which support the agency's biomedical research and public health initiatives. Qiagen has provided similar molecular diagnostics...
The National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, awarded a firm fixed-price purchase order worth $9,329.75 to Qiagen, LLC for a tissue lyser and adapter set. This award is associated with a larger contract vehicle held by Qiagen's parent company, Qiagen N.V., a multinational biotechnology firm that provides sample and assay technologies to federal agencies, including the NIH, CDC, VA, and DOD. Qiagen has...